期刊文献+

间苯三酚联合黄体酮治疗先兆流产的有效性及影响探析 被引量:6

Efficacy and Impact of Phloroglucinol Combined With Progesterone in the Treatment of Threatened Abortion
下载PDF
导出
摘要 目的研究分析在先兆流产孕妇治疗中采用黄体酮、间苯三酚联用的治疗效果。方法研究样本选自本院2016年1月—2017年1月收治的80例先兆流产孕妇,采用随机选取法将其分为对比组与研究组,对比组为黄体酮治疗方案孕妇,研究组为黄体酮、间苯三酚联用治疗方案孕妇,比较两组孕妇治疗效果。结果研究组孕妇与对比组孕妇治疗成功率、不良反应发生率、术后生活质量影响等指标组间差异具有统计学意义,其中研究组较为优异(P<0.05)。结论先兆流产采用黄体酮、间苯三酚联用治疗,可有效提高治疗效果,改善孕妇生活质量。 Objective To study and analyze therapeutic effect of progesterone and pyrogallol in the treatment of pregnant women with threatened abortion. Methods 80 patients with threatened abortion admitted from January 2016 to January 2017 were randomly divided into control group and study group. The patients in the control group were treated with progesterone, the patients in the study group were treated with progesterone, and the patients in the study group were treated with phloroglueinol. Results The success rate of the patients in the study group and the control group was higher than that in the control group. There were significant differences in the incidence of adverse reactions and the influence of quality of life after operation between the two groups (P 〈 0.05). Conclusion Threatened abortion treated with progesterone aod pyrogallol can effectively improve the therapeutic effect and improve the quality of life of natients.
作者 郭军
出处 《中国卫生标准管理》 2018年第4期73-74,共2页 China Health Standard Management
关键词 先兆流产 黄体酮 间苯三酚联 治疗效果 threatened abortion progesterone pyrogallol therapeutic effect
  • 相关文献

参考文献8

二级参考文献81

  • 1王静.先兆流产病因研究进展[J].齐鲁护理杂志,2007,13(9):100-101. 被引量:14
  • 2郝焰,翟桂荣,段爱红.间苯三酚复合剂在产程中应用的研究[J].中华妇产科杂志,2004,39(9):606-608. 被引量:148
  • 3杜继红,郑迅风,黄浩.血清CA125与早期先兆流产妊娠预后的关系[J].南华大学学报(医学版),2006,34(1):97-98. 被引量:11
  • 4罗丽兰.不孕与不育[M].北京:人民卫生出版社,2000.359.
  • 5Parant,O,Maillard,F, Tsatsaris,V et al.Managcment of threatened preterm delivery in France: a national practice survey (the EVAPRIMA study).[J].British journal of Obstetrics and Gynaecology,2008;115( 12): 1538 - 1546.
  • 6Kalinka J,Szekeres Bartho J.The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion.[J].American Journal of Reproductive Immunology,2005;53 (4): 166 - 171.
  • 7Pabuceu R, Akar ME.Luteal phase support in assisted reproductive technology[J].Curr Opin Obstet Gynecol, 2005,17 ( 3 ) : 277-27g.
  • 8谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 9Parant O,Maillard F,Tsatsaris V,et al,Management of threatened preterm deliveryin France: a national practice survey (the EVAPRIMA study)[J].BJOG,2008,115(12):1 538-1 546.
  • 10Gall TM,Oniscu GC,Madhavan K,et al.Surgical management and longterm follow-up of non-parasitic hepatic cysts [J].HPB,2009,11 (3):235-241.

共引文献93

同被引文献47

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部